Loading...
•
Jun 30, 2020
Agenus Q2 2020 Earnings Report
Agenus reported financial results and provided an R&D and business update.
Key Takeaways
Agenus reported a net loss of $48 million, or $0.28 per share, for the second quarter of 2020. The company's cash balance at the end of the quarter was $79 million. Agenus recognized revenue of $26.945 million for the quarter.
Ended the second quarter of 2020 with a cash balance of $79 million.
Net loss for the second quarter ended June 30, 2020 was $48 million or $0.28 per share.
Completed partnership with Betta Pharmaceuticals with $35M in cash and equity received.
Balstilimab BLA filing to be initiated in current quarter.
Agenus
Agenus
Agenus Revenue by Segment
Revenue by Segment
Non-cash royalty Revenue
CapyFin.com Forward Guidance
Based on current plans and projections, Agenus' cash position will be sufficient to support operations into the third quarter of 2021.